|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Risky birth control: Depo-Provera. |
| New Republic. 1974 Nov 9;171(19):7-8. |
| Depo-Provera, the injectable contraceptive developed by Upjohn Company which lasts for 3 months, is controversial. |
| It has been shown to produce side effects, including prolonged vaginal bleeding, increased risk of cancer, and |
| prolonged infertility following use. The administrators at the U.S. Food and Drug Administration and the population |
| division of the Agency for International Development are supporting certification of Depo-Provera for use in the U.S. |
| and distribution outside the country. They focus their main priority on the dangers of population growth rather than |
| the health risks associated with the contraceptive. These administrators are also willing to condone use of Depo- |
| Provera, despite the controversy surrounding its safety, for certain social segments of the population, i.e., the |
| retarded and ethnic minority groups. (PubHealth.info Document ID: CONT7T 3528-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Risky birth control: Depo-Provera.", is(are) Zwerdling D. |
| The source of this article is "New Republic. 1974 Nov 9;171(19):7-8.". This article was published in 1974 in English |
| language(s). (PubHealth.info® Document ID: CONT7T 3528-06. All rights reserved with PubHealth.info) PIN: 33528 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |